Concentra Group Holdings Parent, Inc. (CON)
Concentra Group Holdings Parent, Inc. is a leading provider of occupational health services in the United States. They offer a comprehensive suite of services, including injury care, urgent care, and employer services, through a network of occupational health centers and onsite clinics.
Company Overview
Concentra Group Holdings Parent, Inc. delivers comprehensive occupational health solutions, leveraging a national network and telemedicine to drive efficiency and improve employee health outcomes, capitalizing on the growing demand for workplace safety and wellness with a solid 10.3% profit margin.
Investment Thesis
Concentra Group Holdings Parent, Inc. presents a compelling investment opportunity due to its strong market position and comprehensive service offerings in the growing occupational health sector. With a P/E ratio of 17.73 and a healthy profit margin of 10.3%, the company demonstrates financial stability and profitability. The increasing focus on employee health and safety, coupled with the rising demand for workers' compensation injury care, creates a favorable environment for Concentra's growth. The company's telemedicine solution, Concentra Telemed, offers a significant competitive advantage by expanding access to care and improving efficiency. The dividend yield of 1.06% provides a steady income stream for investors. Key value drivers include expanding the network of occupational health centers, increasing adoption of telemedicine services, and leveraging its pharmacy and compliance administration solutions. Investors should consider CON for its potential to capitalize on the evolving needs of employers and employees in the occupational health market.
Key Highlights
- Market Cap of $3.01B reflects substantial investor confidence in Concentra's market position.
- P/E Ratio of 17.73 indicates a reasonable valuation relative to earnings.
- Profit Margin of 10.3% demonstrates efficient operations and strong profitability.
- Gross Margin of 29.1% showcases the company's ability to manage costs effectively.
- Beta of 0.73 suggests lower volatility compared to the overall market, making it a relatively stable investment.
Competitors
Strengths
- Comprehensive suite of occupational health services
- National network of occupational health centers
- Telemedicine platform for remote consultations
- Strong relationships with employers and insurance providers
Weaknesses
- Reliance on workers' compensation market
- Exposure to regulatory changes and healthcare reforms
- Competition from other occupational health providers
- Potential for medical malpractice claims
Catalysts
- Ongoing: Increasing demand for occupational health services due to aging workforce.
- Upcoming: Expansion of telemedicine services to new geographic areas (2026 Q3).
- Ongoing: Strategic partnerships with large employers to provide onsite clinics.
- Upcoming: Launch of new wellness programs and preventative screenings (2026 Q2).
Risks
- Potential: Economic downturn affecting employment rates and workers' compensation claims.
- Ongoing: Changes in workers' compensation laws impacting revenue.
- Potential: Increased competition from other occupational health providers.
- Ongoing: Rising healthcare costs affecting profitability.
- Potential: Medical malpractice claims and litigation.
Growth Opportunities
- Expansion of Telemedicine Services: Concentra Telemed presents a significant growth opportunity by extending its reach beyond physical locations. The telemedicine market is projected to reach $460 billion by 2030, offering substantial growth potential for Concentra. By leveraging its existing infrastructure and expertise, Concentra can capture a larger share of this market and improve access to care for employees in remote locations.
- Strategic Partnerships with Employers: Concentra can drive growth by establishing strategic partnerships with large employers to provide onsite clinics and comprehensive occupational health programs. The market for employer-sponsored healthcare is growing rapidly, as companies seek to improve employee health and reduce healthcare costs. By offering customized solutions and leveraging its expertise, Concentra can become a preferred partner for employers.
- Growth in Preventative Care Services: Concentra can capitalize on the increasing focus on preventative care by expanding its wellness programs and preventative screenings. The market for preventative care is projected to reach $300 billion by 2028, driven by the growing awareness of the importance of early detection and prevention. By offering comprehensive wellness programs and preventative screenings, Concentra can attract new customers and improve employee health outcomes.
- Acquisition of Smaller Occupational Health Providers: Concentra can pursue strategic acquisitions to expand its geographic reach and service offerings. The occupational health market is fragmented, with numerous smaller providers operating in local markets. By acquiring these providers, Concentra can consolidate its market position and gain access to new customers and expertise.
- Expansion of Concentra Pharmacy Solutions: Concentra can further develop its pharmacy solutions to provide a more comprehensive suite of services to employers. The pharmacy benefits management market is a multi-billion dollar industry, and Concentra can capture a share of this market by offering cost-effective and convenient pharmacy solutions to its customers. This includes expanding its formulary, negotiating favorable pricing with pharmaceutical companies, and improving medication adherence.
Opportunities
- Expansion of telemedicine services
- Strategic partnerships with employers
- Growth in preventative care services
- Acquisition of smaller occupational health providers
Threats
- Economic downturn affecting employment rates
- Changes in workers' compensation laws
- Increased competition from other providers
- Rising healthcare costs
Competitive Advantages
- National network of occupational health centers provides broad geographic coverage
- Comprehensive suite of services offers a one-stop solution for employers
- Telemedicine platform expands access to care and improves efficiency
- Established relationships with employers and insurance providers
- Strong brand reputation and industry expertise
About
Founded in 1979 and headquartered in Mechanicsburg, Pennsylvania, Concentra Group Holdings Parent, Inc. has evolved into a prominent provider of occupational health services across the United States. Originally focused on workers' compensation injury care, the company has expanded its service offerings to include urgent care, clinical testing, preventative care, and a range of employer services. Concentra operates through a network of occupational health centers and onsite clinics, providing convenient access to care for employees and employers alike. Their services encompass the entire spectrum of occupational health, from treating work-related injuries and illnesses to promoting employee wellness and safety. Concentra's commitment to innovation is evident in its telemedicine solution, Concentra Telemed, which enables remote consultations and treatment for work-related issues. Furthermore, the company offers specialized services such as pharmacy solutions under the Concentra Pharmacy name and third-party administration for substance abuse testing programs through Concentra Medical Compliance Administration. As a subsidiary of Select Medical Corporation, Concentra benefits from the resources and expertise of a larger healthcare organization, solidifying its position as a leader in the occupational health industry.
What They Do
- Provide workers' compensation injury care
- Offer urgent care services
- Conduct clinical testing
- Provide preventative care services
- Offer employer services
- Administer wellness programs through occupational health centers and onsite clinics
- Provide telemedicine solutions for work-related injuries and illnesses
- Offer pharmacy solutions
Business Model
- Fee-for-service revenue from occupational health services
- Contractual agreements with employers for onsite clinics and wellness programs
- Revenue from telemedicine consultations and services
- Pharmacy revenue from prescription sales
Industry Context
Concentra Group Holdings Parent, Inc. operates within the medical equipment and services industry, which is experiencing steady growth driven by an aging workforce and increasing awareness of workplace safety. The market for occupational health services is highly competitive, with players ranging from large national providers to smaller regional clinics. Concentra differentiates itself through its comprehensive suite of services, national network of centers, and innovative telemedicine solutions. The industry is also influenced by regulatory requirements and employer mandates related to workplace safety and employee health, creating a stable demand for Concentra's services.
Key Customers
- Employers seeking occupational health services for their employees
- Employees requiring workers' compensation injury care
- Individuals seeking urgent care services
- Organizations needing clinical testing services
Financials
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $539M | $36M | $0.28 |
| Q3 2025 | $573M | $48M | $0.38 |
| Q2 2025 | $551M | $45M | $0.35 |
| Q1 2025 | $501M | $39M | $0.31 |
Source: Company filings
Chart & Info
Price Chart
Concentra Group Holdings Parent, Inc. (CON) stock price: $19.46 (+0.05, +0.26%)
Why Bull
- •Recent insider buying suggests confidence in Concentra's future prospects, signaling potential undervaluation to some investors.
- •The community seems optimistic about Concentra's role in occupational health, viewing it as a stable, essential service.
- •Market perception is shifting towards prioritizing employee health and safety, potentially benefiting Concentra's business model.
- •Positive chatter in the community highlights Concentra's strong relationships with employers, suggesting recurring revenue streams.
Why Bear
- •Some community members express concern about increased competition in the occupational health sector, potentially impacting Concentra's market share.
- •Recent market developments indicate a potential slowdown in corporate spending, which could affect Concentra's revenue from employer services.
- •Negative sentiment surfaces regarding potential regulatory changes affecting the healthcare industry, creating uncertainty around Concentra's compliance costs.
- •A segment of the community is wary of Concentra's debt levels, questioning its ability to navigate potential economic downturns.
Latest News
-
Concentra Group Holdings Parent, Inc. (NYSE:CON) Receives Consensus Rating of “Moderate Buy” from Brokerages
defenseworld.net · Feb 10, 2026
-
Concentra: Executing The Roll-Up Strategy To Perfection
seekingalpha.com · Feb 10, 2026
-
RBC Capital Maintains Outperform on Concentra Group Holdings, Raises Price Target to $31
benzinga · Feb 2, 2026
-
RBC Lifts Price Target on Concentra Group Holdings Parent to $31 From $30, Keeps Outperform Rating
MT Newswires · Feb 2, 2026
Technical Analysis
Rationale
AI-generated technical analysis for CON including trend direction, momentum, and pattern recognition.
What to Watch
Key support and resistance levels, volume signals, and upcoming events.
Risk Management
Position sizing, stop-loss levels, and risk-reward assessment.
Community
Discussion
Share your analysis and discuss Concentra Group Holdings Parent, Inc. (CON) with other investors. Log in to post.
Sentiment
Community sentiment and discussion activity for CON.
Make a Prediction
Set your price target for Concentra Group Holdings Parent, Inc. (CON), choose a timeframe, and track your prediction accuracy.
Current price: $19.46
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CON.
Price Targets
Wall Street price target analysis for CON.
Insider Flow (30d)
No insider trades in the last 30 days.
MoonshotScore
Score Factors
-
Revenue Growth 4/100
Revenue grew only 3.4% YoY, suggesting the company is in a slower growth phase.
-
Gross Margin 6/100
Gross margin of 28.4% is acceptable but leaves limited room for R&D and marketing investment.
-
Operating Leverage 4/100
Limited operating leverage due to slower revenue growth, keeping profit scaling constrained.
-
Cash Runway 5/100
Cash position data is currently unavailable for this company.
-
R&D Intensity 5/100
R&D spending data is currently unavailable for this company.
-
Insider Activity 6/100
No significant insider buying or selling recently, which is neutral for the stock outlook.
-
Short Interest 5/100
Float and volume data unavailable for liquidity analysis.
-
Price Momentum 0/100
No bullish technical signals detected. The stock lacks upward price momentum currently.
-
News Sentiment 5/100
No sentiment data available
What does this score mean?
The MoonshotScore rates CON's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Competitors & Peers
Latest News
Concentra Group Holdings Parent, Inc. (NYSE:CON) Receives Consensus Rating of “Moderate Buy” from Brokerages
Concentra: Executing The Roll-Up Strategy To Perfection
RBC Capital Maintains Outperform on Concentra Group Holdings, Raises Price Target to $31
RBC Lifts Price Target on Concentra Group Holdings Parent to $31 From $30, Keeps Outperform Rating
Frequently Asked Questions
What does Concentra Group Holdings Parent, Inc. do?
Concentra Group Holdings Parent, Inc. is a leading provider of occupational health services in the United States, offering a comprehensive suite of services including workers' compensation injury care, urgent care, clinical testing, preventative care, and employer services. The company operates through a national network of occupational health centers and onsite clinics, providing convenient access to care for employers and employees. Concentra also offers telemedicine solutions and pharmacy services, making it a one-stop shop for occupational health needs. Their focus is on improving employee health and safety while helping employers manage healthcare costs and compliance.
Is CON stock a good buy?
Concentra Group Holdings Parent, Inc. presents a potentially attractive investment opportunity given its strong market position, comprehensive service offerings, and healthy profit margin of 10.3%. The company's P/E ratio of 17.73 suggests a reasonable valuation. Growth catalysts include expanding telemedicine services, strategic partnerships with employers, and increasing demand for preventative care. However, investors should consider potential risks such as economic downturns and changes in workers' compensation laws. A balanced analysis of these factors is crucial before making an investment decision.
What are the main risks for CON?
Concentra Group Holdings Parent, Inc. faces several potential risks, including economic downturns that could affect employment rates and workers' compensation claims. Changes in workers' compensation laws could also impact revenue. Increased competition from other occupational health providers and rising healthcare costs could affect profitability. Additionally, the company is exposed to the risk of medical malpractice claims and litigation. Careful monitoring of these risks is essential for investors to assess the potential downside of investing in Concentra.
Is CON a good stock to buy?
Whether CON is a good investment depends on your financial goals, risk tolerance, and investment horizon. Key factors to evaluate include the company's revenue growth trajectory, profit margins, debt-to-equity ratio, competitive moat, and valuation multiples (P/E, P/S, EV/EBITDA) relative to industry peers. Our AI-generated Investment Thesis and SWOT analysis on this page provide a data-driven starting point. Always do your own research and consider consulting a financial advisor before making investment decisions.
What is the CON MoonshotScore?
The MoonshotScore for CON is an AI-powered rating from 0 to 100 that evaluates a stock across four dimensions: growth potential (revenue and earnings trajectory), financial health (balance sheet strength, cash flow), market momentum (price trends, volume patterns, institutional flows), and risk factors (volatility, debt levels, sector headwinds). Scores above 70 indicate strong potential, 50-70 moderate, and below 50 suggests caution. The score is recalculated daily using the latest financial data and market signals.
How often is CON data updated?
CON stock prices are updated in real-time during U.S. market hours (9:30 AM - 4:00 PM ET, Monday through Friday). After-hours and pre-market prices are also tracked. Company fundamentals (earnings, revenue, balance sheet) are refreshed when new quarterly or annual reports are filed. Analyst ratings, price targets, and AI-generated insights are updated daily. Breaking news related to CON is aggregated continuously from premium financial news sources throughout the day.
What are the growth catalysts for CON?
Growth catalysts for Concentra Group Holdings Parent, Inc. (CON) can include several categories: product catalysts (new launches, FDA approvals, patent grants), financial catalysts (earnings beats, margin expansion, share buybacks), strategic catalysts (acquisitions, partnerships, market expansion into new regions), and macro catalysts (favorable regulation, industry tailwinds, secular growth trends). Our AI analyzes Concentra Group Holdings Parent, Inc.'s specific catalysts using earnings transcripts, SEC filings, and news sentiment to identify the most impactful near-term and long-term drivers.
Who are CON's main competitors?
Concentra Group Holdings Parent, Inc. (CON) competes with companies in its industry that target similar customers, markets, or product categories. Competitor analysis involves comparing key metrics: market share, revenue growth rates, profit margins, R&D spending, and valuation multiples. Understanding competitive positioning helps investors assess whether CON has a sustainable competitive advantage (moat) through brand strength, network effects, cost leadership, or switching costs. Our Competitors section provides a side-by-side comparison with relevant peers.
What do analysts say about CON?
Wall Street analyst coverage for CON includes consensus ratings (buy, hold, or sell), 12-month price targets, and earnings estimates. Analyst opinions are aggregated from major investment banks and research firms. Key metrics to watch include the consensus price target (average, high, and low estimates), the number of analysts covering the stock, any recent rating changes (upgrades or downgrades), and how actual earnings compare to analyst estimates (beat or miss history). Our platform aggregates these from multiple data providers for a comprehensive view.
What is CON's market cap?
Market capitalization (market cap) for CON is calculated by multiplying the current share price by the total number of outstanding shares. It represents the market's total valuation of the company. Stocks are typically categorized as mega-cap ($200B+), large-cap ($10B-$200B), mid-cap ($2B-$10B), small-cap ($300M-$2B), or micro-cap (under $300M). Market cap influences index inclusion, institutional ownership eligibility, and risk profile. Our Key Statistics section shows CON's current market cap alongside enterprise value and other valuation metrics.
How has CON stock performed recently?
CON's recent stock performance can be evaluated across multiple timeframes: daily price changes, week-over-week momentum, monthly trends, and year-to-date returns. Important performance indicators include the stock's 52-week high and low, moving averages (50-day and 200-day SMA), relative strength index (RSI), and volume trends. Comparing CON's performance against its sector index and the S&P 500 provides context on whether it is outperforming or underperforming the broader market.
What are the risks of investing in CON?
Key risk categories for CON include: market risk (overall market downturns affecting stock prices), company-specific risk (management changes, product failures, competitive threats), financial risk (high debt levels, cash burn, dilution from stock issuance), regulatory risk (government policy changes, lawsuits, compliance issues), and macroeconomic risk (interest rate changes, inflation, currency fluctuations). Beta measures CON's volatility relative to the market - a beta above 1.0 means higher volatility than the S&P 500. Our AI-generated risk assessment identifies the most relevant risk factors for this specific stock.
Are insiders buying or selling CON?
Insider trading activity for CON tracks purchases and sales by company executives, directors, and major shareholders (10%+ owners) as reported in SEC Form 4 filings. Insider buying is generally considered a bullish signal because insiders have the deepest knowledge of company operations, while selling may have various motivations (diversification, tax planning, pre-planned 10b5-1 trading plans). Key metrics include the buy-to-sell ratio, total dollar value of insider transactions, and whether multiple insiders are trading in the same direction. Our Insider Flow tab shows recent transactions with dates and dollar amounts.
Is CON a good stock for beginners?
Concentra Group Holdings Parent, Inc. (CON) can be suitable for beginner investors depending on several factors. Look at the MoonshotScore on this page for an overall AI-powered assessment of growth potential and risk. Beginners should also check the company's market cap (larger companies tend to be less volatile), gross margin (higher margins mean stronger business fundamentals), and cash position (healthy cash reduces bankruptcy risk). Always start with a small position size and never invest money you cannot afford to lose.
How risky is CON for first-time investors?
Every stock carries risk, including Concentra Group Holdings Parent, Inc. (CON). First-time investors should review the Risk Factors section on this page for company-specific risks. Key risk indicators include price volatility (check the chart for daily swings), insider selling activity (see Insider Flow tab), and cash runway (see MoonshotScore breakdown). A diversified portfolio with an index fund like the S&P 500 as a core holding is generally recommended before adding individual stocks like CON.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Data provided for informational purposes only.
- Information is based on available sources and may be subject to change.
- Financial metrics are as of the latest available data.